<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cell cycle kinetics in peripheral blood lymphocytes from 30 patients with <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e>, including non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> [10], <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphoblastic <z:hpo ids='HP_0001909'>leukemias</z:hpo> [10], and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> [10] were studied </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty <z:mpath ids='MPATH_458'>normal</z:mpath> healthy subjects formed the control group </plain></SENT>
<SENT sid="2" pm="."><plain>Non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients showed an elongation of the cell cycle time (43% of metaphases in the first cycle), whereas leukemic patients presented a shortening of the cell cycle progression with 46% of cells in the third division </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> showed most of the metaphases (55%) in the second cycle </plain></SENT>
</text></document>